Skip to main content
. 2022 Mar 17;13:815598. doi: 10.3389/fimmu.2022.815598

Table 2.

Fifteen cases of refractory PRMS including this one.

No. Age Location Treatment Metastasis and recurrent Prognosis Reference
1 80 Neck Surg, chemo Skin Died of disease (13)
2 70 Left thigh Chemo Lung Alive without disease 12 months (14)
3 19 Right thigh Immu Lung Durable CR after 12 months (15)
4 78 Sacrum Surg Liver, lung Died of disease after 12 months (16)
5 43 Leg NA Lung Died of disease after 6 months (17)
6 77 Arm Surg, chemo Regional LN Alive without disease 13 months (18)
7 72 Scalp Surg, chemo Skin, regional LN Alive uncertain disease status 23 months (18)
8 78 Leg Surg Lung Died of disease after 12 months (18)
9 41 Orbit Surg, chemo Lung, bone, local recurrence Died of disease after 6 months (19)
10 65 Submandibular Surg, chemo Local recurrence Alive without disease 12 months (20)
11 89 cheek Surg Local recurrence Died of disease after 2 months (21)
12 90 Uterine Surg NA Dies of disease after 6 months (14)
13 80 Uterine Surg, chemo NA Died of disease after 6 months (14)
14 50 Back Surg, chemo Regional LN Alive with disease 2 months (22)
15 12 Left elbow Surg, immu Lung metastasis Durable CR after 45 months Present case

Chemo, chemotherapy; Immu, immunotherapy; LN, lymph nodes; NA, not available; Surg, surgery.